VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop  

NEXT STORY
BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity
PREV STORY
Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Anthera Pharmaceuticals Announces RESULT Phase 3 Clinical Study of Sollpura will be included in the Cystic Fibrosis Foundation Therapeutics Development Network

HAYWARD, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals (Nasdaq:ANTH) today announced that ...

author_avatar
NASDAQ Market News

Platelet-rich Plasma Market to Reach US$ 543.5 Mn by 2026; Rise in Number of Orthopedic and Sport Injuries to Boost Market – Transparency Market Research

Platelet-rich Plasma Market (Type - Pure Platelet-rich Plasma, Leukocyte-rich Platelet-rich Plasma, Pure Platelet-rich Fibrin; ...

author_avatar
NASDAQ Market News

Dr. Steven Altschuler, Former CEO of CHOP, Joins Diversified Search

PHILADELPHIA, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Dr. Steven Altschuler, a renowned physician-leader who ...

author_avatar
NASDAQ Market News